Fred Muhletaler
Henry Ford Hospital, Henry Ford Health System, Michigan United
Papers
7
Total Citations
594
H-Index
6
About
Fred Muhletaler is a leading urologic surgeon and researcher whose work has fundamentally advanced the field of robotic-assisted urologic oncology. His primary research areas include optimizing surgical techniques for prostate and bladder cancer, with a particular focus on improving patient quality of life through enhanced functional outcomes. Muhletaler’s most impactful contribution is his landmark randomized controlled trial on periprostatic tissue reconstruction during robotic prostatectomy (228 citations), which provided the first high-level evidence that specific reconstructive techniques significantly accelerate the return of urinary continence. He further refined this work with a long-term study comparing single- versus double-layer urethrovesical anastomosis, demonstrating sustained benefits over two years. As a key member of the International Robotic Cystectomy Consortium, he co-authored a major multi-institutional analysis of complications after robot-assisted cystectomy (225 citations), establishing critical safety benchmarks. Muhletaler also pioneered the lateral camera port placement technique for robotic renal surgery, a practical innovation that reduced arm collisions and expanded surgical access. His research has directly shaped modern surgical protocols, helping thousands of patients achieve faster recovery and better continence after cancer surgery.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5
- 6
- 7